Aumovio (AMV0) Pre-close call summary
Event summary combining transcript, slides, and related documents.
Pre-close call summary
9 Feb, 2026Executive summary
Achieved significant transformation progress, strengthened performance culture, and increased agility since listing in September.
Inclusion in the MDAX at the end of December marked a key milestone.
FY 2025 sales are expected in the range of €18.0-19.0bn, with adjusted EBIT margin at the upper end of 2.5%-4.0% guidance.
Free cash flow generation remains a top priority, with ambitions for positive adjusted free cash flow in 2025, even after restructuring and spin-off costs.
Focused on projects contributing positively to midterm profitability and streamlined portfolio through divestments and winding down non-core businesses.
Trading performance and revenue trends
Global light vehicle production rose 1% in Q4, with FY 2025 expected to increase by 4%, led by 10% growth in China, while Europe and North America are expected to see slight declines.
Regional declines in Europe and North America impacted sales, as these regions represent about 75% of group sales.
Sales were negatively affected by winding down build-to-print business, phasing out contract manufacturing, divestments, and currency effects, mainly due to a stronger Euro.
Q4 sales development aligns with current guidance for FY2025.
Profitability and margins
Adjusted EBIT margin for the first nine months was 2.9%, with the year-end quarter and FY 2025 expected to reach the upper end of the 2.5%-4.0% guidance range.
Self-help programs continue to drive fixed-cost savings in administration and R&D, supporting mid-term profitability targets.
Q4 is seasonally strongest due to customer reimbursements.
Tariff impacts remain limited due to USMCA-compliant imports.
Latest events from Aumovio
- EBIT rose 45% to €717mn despite 5% sales drop, with strong cash flow and liquidity maintained.AMV0
Q4 202518 Mar 2026 - EBIT up 146% on cost savings; 2025 guidance narrowed, margin outlook raised.AMV0
Q3 20257 Nov 2025 - EUR 30.1 million net loss and EUR 29.9 million equity deficit, with IPO-related expenses.AMV0
Q2 202526 Sep 2025